VERA earnings: real EPS beat/miss history, analyst consensus Buy, P/E -6.51. Updated 2026-07-23.
Vera Therapeutics (VERA) Research Hub
Vera Therapeutics (VERA) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 35.05 USD (+3.76%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -6.51, market cap 2.60B. This hub links to the full technical, earnings and options research available for VERA.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 35.05 USD (+3.76%) |
| 52-week range | 28.86 USD – 44.87 USD |
| Trend regime | Range |
| 14-day RSI | 55.5 (Bullish) |
| Trailing P/E | -6.51 |
| Market cap | 2.60B |
| Dividend yield | 0.00% |
Available research for VERA
Covered Call on VERA: how it works, illustrative setup around the real 35.05 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on VERA: how it works, illustrative setup around the real 35.05 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on VERA: how it works, illustrative setup around the real 35.05 USD price, max profit/loss, breakeven and when to use it. Educational.
VERA technical analysis: range, last 35.05 USD, RSI 55.5, 52w range 28.86 USD–44.87 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is VERA in?
Vera Therapeutics (VERA) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is VERA in an uptrend or downtrend?
As of 2026-09-11, VERA is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is VERA's trailing P/E ratio?
VERA's trailing P/E is -6.51, with a market cap of 2.60B. See the earnings research page for full valuation detail.